Postarrest stalling rather than crawling favors CD8(+) over CD4(+) T-cell migration across the blood-brain barrier under flow in vitro. by Rudolph, Henriette et al.
Eur. J. Immunol. 2016. 46: 2187–2203 Henriette Rudolph et al.DOI: 10.1002/eji.201546251 2187
B
asic
Tissue immunology and leukocyte trafficking
Research Article
Postarrest stalling rather than crawling favors CD8+
over CD4+ T-cell migration across the blood–brain
barrier under flow in vitro
Henriette Rudolph∗, Armelle Klopstein∗, Isabelle Gruber, Claudia Blatti,
Ruth Lyck and Britta Engelhardt
Theodor Kocher Institute, University of Bern, Bern, Switzerland
Although CD8+ T cells have been implied in the pathogenesis of multiple sclerosis (MS),
the molecular mechanisms mediating CD8+ T-cell migration across the blood–brain bar-
rier (BBB) into the central nervous system (CNS) are ill defined. Using in vitro live cell imag-
ing, we directly compared the multistep extravasation of activated CD4+ and CD8+ T cells
across primary mouse brain microvascular endothelial cells (pMBMECs) as a model for
the BBB under physiological flow. Significantly higher numbers of CD8+ than CD4+ T cells
arrested on pMBMECs under noninflammatory and inflammatory conditions.While CD4+
T cells polarized and crawled prior to their diapedesis, the majority of CD8+ T cells stalled
and readily crossed the pMBMECmonolayer preferentially via a transcellular route. T-cell
arrest and crawling were independent of G-protein-coupled receptor signaling. Rather,
absence of endothelial ICAM-1 and ICAM-2 abolished increased arrest of CD8+ over
CD4+ T cells and abrogated T-cell crawling, leading to the efficient reduction of CD4+,
but to a lesser degree of CD8+, T-cell diapedesis across ICAM-1null/ICAM-2−/− pMBMECs.
Thus, cellular and molecular mechanisms mediating the multistep extravasation of acti-
vated CD8+ T cells across the BBB are distinguishable from those involved for CD4+
T cells.
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Introduction
Multiple sclerosis (MS) is the most common inflammatory
demyelinating disease of the central nervous system (CNS). The
etiology of the disease remains a subject of debate especially as
distinct subtypes of this disease exist with regard to progression,
severity of various neurological symptoms, and histopathological
presentation [1]. The anti-inflammatory and immunosuppressive
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therapies available at present delay the course of some forms of
the disease and support the notion of an underlying autoimmune
pathogenesis.
Much of our current understanding about the pathogenesis of
MS has been derived from its animal model experimental autoim-
mune encephalomyelitis (EAE). The classical EAE models rely
on immunization with CNS-derived autoantigens emulsified in
aggressive immune adjuvants, thereby favoring the activation of
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CD4+ T cells and the induction of autoantibodies. Both, CD4+
Th1 cells and Th17 cells (summarized by [2]) and more recently
also GM-CSF granulocyte macrophage colony stimulating factor
producing CD4+ T-cell subsets [3] have been shown to play key
pathogenic roles in triggering EAE.
In MS itself, however, accumulating evidence suggests that the
role of CD8+ T cells in the autoimmune attack has been largely
underestimated until recently [4]. Indeed, CD8+ T cells accumu-
late within white matter lesions, where they often outnumber
CD4+ T cells and are found in close association with oligodendro-
cytes and demyelinated axons [5, 6]. In addition, CD8+ T cells
harboring an effector memory phenotype were shown to accumu-
late in the cerebrospinal fluid (CSF) and in the inflamed CNS ofMS
patients, and these cells exhibit cytotoxic and inflammatory poten-
tial as they express granzyme B and IFN-γ at high frequency [7].
More recently, CD8+ T cells were even detected in immune cell
infiltrates in cortical demyelinating lesions, which are prevalent
at early stages of MS [8] underscoring an involvement of CD8+
T cells at early time points of MS pathogenesis. Analyses of T-cell
receptor (TCR) usage by CNS infiltrating T cells provided evidence
for oligoclonal expansion of CD8+ but not CD4+ T cells within MS
lesions [9, 10] and the CSF [11], which is a likely consequence of
their local major histocompatibility complex (MHC) class I depen-
dent antigen-driven activation. Furthermore, recent genetic stud-
ies showed a link between certain MHC class I alleles and MS
susceptibility [12–15]. Collectively, these data suggest that CD8+
T-cell clones with shared antigen specificity have migrated to the
CNS independently and have locally responded to a given set of
CNS antigens.
The migration of circulating autoagressive T cells into the CNS
is a central step in the pathogenesis of MS and its animal model
EAE. In order to access the CNS the T cells have to cross the
endothelial blood–brain barrier (BBB). The BBB is localized at the
level of CNS microvascular endothelial cells, which by strictly con-
trolling the movement of molecules across their interface provide
a protective barrier of the CNS toward the periphery [16]. The
BBB also establishes the interface between the immune system
and the CNS and therefore closely controls immune cell migration
into the CNS. Our current knowledge on immune cell trafficking
across the BBB into the CNS during MS mostly relies on studies of
the migration of encephalitogenic CD4+ T cells into the CNS in the
context of the classical EAE models (reviewed in [17, 18]). These
studies combined with in vitro and in vivo live cell imaging studies
have shown that the migration of encephalitogenic CD4+ T cells
across the BBB is a multistep process orchestrated by the sequen-
tial interaction of distinct adhesion and signaling molecules [17].
Probably accounting to the high specialization of the BBB endothe-
lial cells, the interaction of encephalitogenic CD4+ T cells with the
BBB is unique and characterized by a predominant involvement of
α4β1-integrin (VLA-4) and the extended crawling of these T cells
against the direction of blood flow on the luminal side of the BBB in
search of sites for diapedesis [17, 19, 20]. Therapeutic targeting of
T-cell migration across the BBB with the anti-α4-integrin antibody
natalizumab has proven efficient in the treatment of relapsing-
remitting MS. As this treatment is associated with an increased
risk for progressive multifocal leukoencephalopathy it has been
suggested that therapeutic targeting of α4-integrins interferes with
CNS immunosurveillance by CD8+ T cells [21, 22].
To gain further insight into the molecular mechanisms guid-
ing CD8+ T cells across the BBB, we made use of in vitro live
cell imaging and directly compared the multistep extravasation of
activated CD4+ and CD8+ T cells across the BBB under physiolog-
ical flow [23–26]. We found subset-specific usage of endothelial
ICAM-1 and ICAM-2 in T-cell arrest and crawling on the BBB
under physiological flow leading to higher numbers of CD8+ ver-
sus CD4+ T cells crossing the BBB. In accordance to our previ-
ous findings activated CD4+ T cells were observed to arrest on
the BBB largely independent of ICAM-1 and ICAM-2, and sub-
sequently polarize and crawl in an ICAM-1/ICAM-2-dependent
manner to sites of diapedesis. In contrast, activated CD8+ T cells
arrested in significantly higher numbers compared to CD4+ T cells
on the BBB and the increased adhesive interaction was mediated
by endothelial ICAM-1 and ICAM-2. Following their arrest CD8+
T cells instead of crawling rather remained stalled and rapidly
crossed the BBB mostly via transcellular routes. Our study thus
shows subset-specific cellular and molecular mechanisms of acti-
vated CD8+ versus CD4+ T-cell migration across the BBB. This
suggests the possibility for developing alternative options for the
therapeutic targeting of the migration of autoagressive T cells into
the CNS allowing to specifically block CNS recruitment of destruc-
tive CD4+ or CD8+ T cells and leave the migration of protective
immune cells into the CNS unaffected.
Results
Activated CD8+ T cells more efficiently arrest on
pMBMECs than activated CD4+ T cells
We have previously shown the differential involvement of α4-
integrin/VCAM-1 and of LFA-1/ICAM-1 in mediating the arrest,
polarization, crawling, and diapedesis of encephalitogenic CD4+
T cells across the BBB [23, 26]. Recent investigations have sug-
gested similar mechanisms allowing for the migration of CD8+
T cells across the BBB [7, 27]. This prompted us to side by side
compare the dynamic interaction of activated CD8+ and CD4+
T cells with primary mouse brain microvascular endothelial cells
(pMBMECs) as in vitro model of the BBB under physiological flow
by live cell imaging [24]. To this end, we chose to study CD8+
and CD4+ T-cell subsets isolated from TCR transgenic OT1 and
OT2 mice, respectively. This allowed for defined and homogenous
in vitro antigen-specific T-cell activation as demonstrated by their
ovalbumin (OVA) specific T-cell proliferation profiles (Supporting
Information Fig. 1) and the induction of a comparable yet not iden-
tical cell surface expression of adhesion molecules on the different
CD8+ and CD4+ T-cell lines established (Supporting Information
Fig. 2A; Supporting Information Table 1).
To study their interaction with the BBB activated CD8+ and
CD4+ T cells were alternately labeled with CellTracker Orange or
CellTracker Green to avoid staining artifacts and subsequently
C© 2016 The Authors. European Journal of Immunology published by
WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
www.eji-journal.eu
Eur. J. Immunol. 2016. 46: 2187–2203 Tissue immunology and leukocyte trafficking 2189
Figure 1. Activated CD8+ T cells arrest more efficiently than CD4+ T cells on stimulated and NS pMBMECs under physiological flow. Analysis of
the postarrest CD4+ and CD8+ T-cell interactions with NS, TNF-α-stimulated (TNF-α) and TNF-α and IFN-γ (TNF-α+IFN-γ) stimulated pMBMECs
under physiological flow was observed by live cell imaging over 20 min. (A) Mean numbers of arrested CD8+ versus CD4+ T cells per FOV (438
× 329 μm) perfused in a 1:1 ratio are shown on NS, TNF-α-stimulated, and TNF-α+IFN-γ costimulated pMBMECs. Data are shown as mean ± SEM
(n = 9 experiments for NS, n = 9 for TNF-α, n = 19 for TNF-α+IFN-γ). *p < 0.05, ****p < 0.00001 CD8+ versus CD4+ T cells. In addition, the increase
in the number of arrested T cells on cytokine stimulated compared to NS pMBMECs was significant for CD8+ T cells for both TNF-α (p < 0.01) and
TNF-α+IFN-γ (p < 0.0001) stimulation, and for CD4+ T cells for stimulation with TNF-α+IFN-γ (p < 0.001). One-way ANOVA, followed by the Tukey
multiple comparison test. (B) Representative images from time-lapse videos showing the arrested CellTrackerGreen (CMFDA) or CellTrackerOrange
(CMTMR) labeled CD8+ versus CD4+ T cells on NS, TNF-α-stimulated and TNF-α+IFN-γ costimulated pMBMECs at 30 to 40 s after increase of the
flow rate. Color of the CD8+ or CD4+ label indicates the CellTracker dye used for labeling the CD8+ and CD4+ T cells in this specific assay.
mixed in a precise 1:1 ratio prior to their superfusion over
pMBMEC monolayers under physiological flow. pMBMECs were
either nonstimulated (NS) or stimulated with TNF-α or TNF-
α+IFN-γ to mimic the in vivo situation of CNS immunosurveil-
lance and neuroinflammation, respectively. Under all conditions,
we found the number of activated CD8+ T cells arresting on
pMBMECs under flow to be significantly higher than the num-
ber of activated CD4+ T cells (Fig. 1 and Supporting Information
Fig. 2B). Under NS conditions 38 ± 6 CD8+ T cells versus 13 ± 2
CD4+ T cells per field of view (FOV) were found to arrest on the
pMBMECs under flow. After stimulation of pMBMECs with TNF-
α or TNF-α+IFN-γ arrest of both, CD8+ and CD4+ T cells was
increased with 68 ± 9 or 75 ± 4 CD8+ T cells/FOV and 25 ± 3
or 44 ± 3 CD4+ T cells/FOV arrested on pMBMECs, respectively
(Fig. 1).
We next considered the influence of the TCR peptide/MHC
affinity on increased CD8+ T cell over CD4+ T cell arrest on the
BBB under physiological flow in vitro. To this end, we relied on
the well characterized interaction of the OT1 TCR with OVA pep-
tides harboring single amino acid differences that were shown
to exhibit different stimulatory potencies on the OT1 cells [28].
We confirmed that the peptide Q4 (SIIQFEKL) reported to have
intermediate affinity interaction with the OT1 TCR [29] showed
lower potency in activating OT1 cells (Supporting Information
Fig. 2C). At the same time, it did not reduce arrest of OT1 cells on
pMBMECs under physiological flow (Supporting Information
Fig. 2D) excluding a direct role for TCR-peptide/MHC affinity
in mediating enhanced arrest of CD8+ over CD4+ T cells on the
BBB under physiological flow in vitro.
Taken together, shear-resistant arrest of activated CD8+ T cells
was found to be significantly more efficient than that of activated
CD4+ T cells under noninflamed and inflamed conditions.
Postarrest stalling rather than crawling favors CD8+
T-cell diapedesis across pMBMECs
In accordance to our previous observations on encephalitogenic
CD4+ T cells [23] the activated CD4+ T cells in this study readily
polarized after shear-resistant arrest and started to crawl over the
pMBMEC monolayers.
To determine the impact of the distinct postarrest behavior
of CD8+ versus CD4+ T cells on pMBMECs on their ability to
migrate across the in vitro BBB under flow we performed a visual
C© 2016 The Authors. European Journal of Immunology published by
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Figure 2. Postarrest dynamic interaction of CD8+ T cells with pMBMECs is distinct from that of CD4+ T cells. Analysis of the postarrest CD4+ and
CD8+ T-cell interactions with NS, TNF-α-stimulated (TNF-α) and TNF-α and IFN-γ (TNF-α+IFN-γ) stimulated pMBMECs under physiological flowwas
observed by live cell imaging over 20 min. (A) Euclidean distance μm (left) and T-cell crawling speed (μm/min) (right) were calculated from T-cell
tracks of at least nine independent movies per condition. CD8+ T cells are shown as black symbols and CD4+ T cells as grey symbols. Normality
testing was performed with D’Agostino and Pearson normality test (omnibus K2) before differences between the stalling and crawling fraction
were analyzed with the one-way ANOVA, followed by the Tukey multiple comparison test. (B) Each T cell was assigned to one of six categories
that are shown in the staple bars as follows: Stalling with diapedesis (left, black), stalling (left, dark grey) and stalling with detachment (left, light
grey); crawling with diapedesis (right, black), crawling (right, dark grey) and crawling with detachment (right, light grey). The number of arrested
T cells per FOV was set to 100% and the six categories are displayed in percent as fraction of arrested T cells. Bars showmeans ± SEM (n = 9 for NS,
n= 9 for TNF-α, n= 22 for TNF-α+IFN-γ). p values displayed indicate the combined differences between crawling CD8+ versus CD4+ T cells or stalling
CD8+ versus CD4+ T cells. *p < 0.05;**p < 0.01. Normality testing was performed with D’Agostino and Pearson normality test (omnibus K2) before
differences between the stalling and crawling fraction were analyzed with the two-way ANOVA, followed by the Tukey multiple comparison test.
Accompanying movies are provided as Supporting Information Videos 1–3). (C) Percentage of overall CD4+ and CD8+ T-cell diapedesis irrespective
of prior crawling or stalling is shown. p values compare the diapedesis rate of stalling CD4+ and CD8+ T cells. One-way ANOVA, followed by the
Tukey multiple comparison test. ****p < 0.00001.
frame-by-frame offline analysis of the time-lapse videos, in which
we quantified the dynamic behavior of CD4+ and CD8+ T cells
arrested on NS, TNF-α, and TNF-α+IFN-γ-stimulated pMBMECs.
The number of initially arrested CD4+ and CD8+ T cells on the
respective pMBMECs were set to 100% and each category was
expressed as the fraction of arrested T cells (Fig. 2B). T cells
were either crawling or stalling after shear-resistant arrest on
pMBMECs. The term “stalling” was specifically chosen to describe
the behavior of those T cells that, following shear-resistant arrest
on pMBMECs, remained within their diameter but visibly and
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actively probed the endothelium for sites of diapedesis. Still,
stalling was not an “inability” of these T cells to crawl as once
beneath themonolayer those T cells were observed to crawl. While
on NS and on TNF-α-stimulated pMBMECs 51 ± 9% and 54 ± 7%
of CD4+ T cells, respectively, were observed to crawl, stimulation
of pMBMECs with TNF-α+IFN-γ reduced the percentage of CD4+
T cells crawling on the pMBMECs to 30 ± 3% (Fig. 2B; Support-
ing Information Videos 1–3). At the same time the percentage
of CD4+ T cells observed to stall after arresting changed accord-
ingly with 49 ± 9% and 46 ± 7% of CD4+ T cells on NS and
TNF-α-stimulated pMBMECs, respectively, and 70 ± 3% of CD4+
T cells after stimulation with TNF-α+IFN-γ (Fig. 2B; Supporting
Information Videos 1–3).
In contrast to CD4+ T cells and irrespective of the presence
or absence of inflammatory stimuli applied to pMBMECs, only
a minority of arrested CD8+ T cells started to crawl on the
pMBMEC monolayers. Rather the majority, namely 72 ± 8% of
CD8+ T cells stalled on the pMBMEC monolayers already under
noninflammatory conditions. Similarly, after stimulation of pMB-
MECs with TNF-α or TNF-α+IFN-γ, 72 ± 5% or 82 ± 3% of CD8+
T cells, respectively, stalled on the pMBMEC monolayers (Fig. 2B;
Supporting Information Videos 1–3).
Next, we determined the crawling speed and crawling distance
of CD4+ and CD8+ T cells on NS and TNF-α or TNF-α+IFN-
γ-stimulated pMBMECs. On the surface of NS pMBMECs the
crawling speed of CD4+ T cells compared to CD8+ T cells was 9.1±
1.1 μm/min versus 5.1 ± 0.1 μm/min (p < 0.0001) (Fig. 2A). On
pMBMECs stimulated with TNF-α and TNF-α+IFN-γ CD4+ T cells
crawled with a speed of 7.4± 0.3μm/min and 10.5± 0.3μm/min
while the crawling speed of CD8+ T cells was 4.7 ± 0.3 μm/min
and 7.8 ± 0.2 μm/min, respectively (p < 0.0001). The Euclidean
distance reached by crawling CD4+ T cells during the 20 min
observation time on NS or TNF-α-stimulated pMBMECswas longer
than the Euclidean distance crawled by CD8+ T cells. However,
on TNF-α+IFN-γ pMBMECs, CD4+ T cells crawled significantly
shorter Euclidean distances (41.1 ± 1.7 μm) than CD8+ T cells
(51.8 ± 2.0 μm, p = 0.0004, Fig. 2A). Taken together, CD4+
T cells crawled significantly faster than CD8+ T cells (Fig. 2A).
In order to understand how the difference in crawling influ-
enced CD4+ and CD8+ T-cell diapedesis across the BBB in vitro
we next assigned each arrested CD4+ and CD8+ T cell to one
of the following six groups: (i) Stalling T cells detaching during
the observation period, (ii) T cells remaining stalled, (iii) stalling
T cells that crossed the pMBMEC monolayer in the observation
period, (iv) T cells that crawled and detached, (v) T cells that
crawled for the entire observation period, and finally (vi) T cells
that crossed the pMBMEC monolayer after crawling (Supporting
Information Video 3). Interestingly, stalling behavior rather than
crawling facilitated CD8+ T-cell diapedesis across the BBB under
flow. While under NS conditions the diapedesis rate of stalling
CD4+ and CD8+ T cells was low and did not differ significantly,
stimulation of pMBMECs with TNF-α or TNF-α+IFN-γ led to a
significantly increased proportion of stalling CD8+ compared to
CD4+ T cells that crossed the pMBMEC monolayers (Fig. 2C).
Specifically, under noninflammatory conditions 4± 1%of arrested
CD8+ versus 1 ± 1% of arrested CD4+ T cells were observed to
cross the pMBMEC monolayers. After stimulation with TNF-α, 33
± 4% versus 9 ± 3% stalled CD8+ and CD4+ T cells, respectively,
and after stimulation with TNF-α+IFN-γ, 39% ± 4% versus 20 ±
3% stalled CD8+ and CD4+ T cells, respectively, crossed the pMB-
MEC monolayers (Fig. 2C; Supporting Information Videos 1–3).
In contrast, the percentage of CD4+ T cells undergoing diapedesis
subsequent to crawling was higher than that of crawling CD8+
T cells (Fig. 2B and C). Taken together, these observations demon-
strate that postarrest behavior of activated CD8+ T cells on pMB-
MECs under flow is distinct from that of activated CD4+ T cells
leading in total to a significantly higher percentage of stalling
but not crawling CD8+ T cells crossing the pMBMEC monolayers
during the observation period when compared to CD4+ T cells
(Fig. 2C).
As stalling behavior seemed to increase the diapedesis of CD8+
versus CD4+ T cells across pMBMEC monolayers we next asked if
crawling of CD8+ and CD4+ T cells delays their diapedesis across
the BBB. To this end, we determined the time between shear-
resistant T-cell arrest on the pMBMEC monolayer and the start
of CD4+ or CD8+ T-cell diapedesis across inflamed pMBMECs
(Fig. 3). Due to too low number of diapedesis events observed
across NS pMBMECs this could not be evaluated under NS
conditions. However, on TNF-α and TNF-α+IFN-γ-stimulated
pMBMECs stalled CD8+ T cells started diapedesis significantly
earlier than crawling CD8+ T cells (Fig. 3A) underscoring the
notion that stalling behavior of the CD8+ T cells accelerates their
diapedesis across the BBB. On TNF-α+IFN-γ-stimulated but not
on TNF-α-stimulated pMBMECs we could observe a similar behav-
ior for activated CD4+ T cells, with stalling CD4+ T cells starting
diapedesis significantly earlier than those that crawled prior to
diapedesis (Fig. 3A). Interestingly, the duration of diapedesis of
crawling CD4+ T cells was significantly shorter than that of stalling
CD4+ T cells (Fig. 3B). In contrast, we observed no significant
differences for the duration of the diapedesis process comparing
stalling and crawling CD8+ T cells. Taken together these observa-
tions further support the notion that the stalling behavior of the
CD8+ T cells shortened the time between arrest and their subse-
quent diapedesis across the pMBMEC monolayer when compared
to CD4+ T cells.
We next asked if stalling behavior of the T cells is induced by
chemotactic factors bound to the luminal surface of the cytokine-
stimulated pMBMEC monolayer. To this end, we pretreated CD8+
and CD4+ T cells with pertussis toxin (PTX) allowing for the inhi-
bition of Gαi-dependent GPCR-mediated inside-out integrin acti-
vation on the T cells. Confirming previous observations by oth-
ers [30] GPCR signaling was not required for the arrest and sub-
sequent crawling of activated CD8+ and CD4+ T cells on TNF-α/
IFN-γ-stimulated pMBMECs (Supporting Information Fig. 3). In
contrast, inhibition of GPCR signaling almost completely abro-
gated CD8+ and CD4+ T cell stalling on and diapedesis across
the pMBMEC monolayers leading to significantly higher fractions
of T cells crawling on the endothelial surface during the observa-
tion time (Supporting Information Fig. 3). Thus, postarrest stalling
and diapedesis of both, activated CD8+ and CD4+ T cells strictly
C© 2016 The Authors. European Journal of Immunology published by
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Figure 3. Stalling behavior of T cells shortens the time until start of diapedesis when compared to crawling T cells. Analysis of the time until
and duration of diapedesis of CD4+ and CD8+ T cells across TNF-α-stimulated (TNF-α) and TNF-α and IFN-γ (TNF-α+IFN-γ) stimulated pMBMECs
under physiological flow observed by live cell imaging over 20 min and evaluated via a frame by frame offline analysis. Each data point represents
a single CD8+ or CD4+ T cell.(A) Time after shear-resistant arrest until the beginning of diapedesis is shown for CD8+ and CD4+ T cells on the
surface of TNF-α-stimulated (TNF-α) and TNF-α+IFN-γ-stimulated (TNF-α+IFN-γ) pMBMECs. Filled black circles represent stalling and filled grey
circles crawling T cells. Values are shown as mean and are pooled from at least nine independent videos per condition. (B) Duration of diapedesis
is shown for CD8+ and CD4+ T cells on the surface of TNF-α-stimulated (TNF-α) and TNF-α+IFN-γ-stimulated (TNF-α+IFN-γ) pMBMECs. *p < 0.05;
**p < 0.01; ***p < 0.001; ****p < 0.0001; One-way ANOVA, followed by the Tukey multiple comparison test. For the condition NS no data are shown
due to low number of events.
depend on signals from Gαi-associated GPCRs. Importantly,
shear-resistant arrest of both, activated CD4+ and CD8+ T cells
on pMBMECs was independent of GPCR signaling (Supporting
Information Fig. 3).
Activated CD8+ T cells cross the pMBMEC monolayer
preferentially via the transcellular route
We have previously shown that reduced crawling of encephali-
togenic CD4+ T cells on IL-1β-stimulated ICAM-1null/ICAM-2−/−
pMBMECs correlated with their preferential transcellular dia-
pedesis [26]. Considering the postarrest stalling of CD8+ T cells
observed in the present study we therefore speculated that CD8+
T-cell diapedesis occurs preferentially via a transcellular pathway.
To investigate the cellular pathway of CD8+ T-cell diapedesis we
isolated pMBMECs from C57BL/6J knock-in mice expressing a
C-terminal GFP fusion protein of VE cadherin in the endogenous
VE cadherin locus (VE-cadherin-GFP, VE-CadGFP pMBMECs),
allowing to visualize the endothelial junctions in live pMBMECs
and thus investigate the pathway of T-cell diapedesis [25, 26]. To
determine paracellular from transcellular diapedesis, we defined
diapedesis events that transiently interrupted the junctional GFP
signal as paracellular diapedesis and those that did not as transcel-
lular diapedesis. When analyzing the diapedesis of activated CD8+
T cells across TNF-α+IFN-γ-stimulated pMBMECs we found that
the majority (77%) crossed the pMBMEC monolayers via the tran-
scellular pathway while the minority (23%) via the paracellular
pathway (Fig. 4, Supporting Information Videos 4 and 5). Thus,
activated CD8+ T cells are able to cross the inflamed BBB by both,
the transcellular and paracellular route with a clear preference for
the transcellular pathway.
TNF-α or TNF-α+IFN-γ induce distinct surface ICAM-1
and VCAM-1 levels on pMBMECs
Having observed the distinct dynamic behavior of activated CD8+
versus CD4+ T cells on pMBMECs we next aimed to further delin-
eate the underlying molecular mechanisms. In previous studies,
we have shown that the arrest of encephalitogenic CD4+ T cells on
pMBMECs is mediated by endothelial VCAM-1 and ICAM-1 [23].
For the subsequent crawling of encephalitogenic CD4+ T cells on
pMBMECs we found essential roles for endothelial ICAM-1 and
ICAM-2 with the cell surface levels of endothelial ICAM-1 deter-
mining the crawling distance and the cellular pathway of CD4+
T cell diapedesis [23, 26]. In the present study, we observed that
the total number of activated CD8+ and CD4+ T cells arresting on
pMBMECs under flow increased after stimulation with TNF-α and
even further after stimulation with TNF-α+IFN-γ (Fig. 1) suggest-
ing increased expression of adhesion molecules on the pMBMECs
after cytokine stimulation.
Performing immunofluorescence (IF) stainings for ICAM-1,
ICAM-2, VCAM-1, and PECAM-1 we detected staining for ICAM-2
and PECAM-1 on all NS pMBMECs. In contrast, ICAM-1 and
VCAM-1 could only be detected on individual pMBMECs (Fig. 5A).
Stimulation with TNF-α or TNF-α+IFN-γ significantly increased
the number of pMBMECs staining positive for ICAM-1 and VCAM-1
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Figure 4. Activated CD8+ T cells cross the inflamed BBB preferentially
via the transcellular route. (A) Paracellular diapedesis of a CD8+ T cell
across TNF-α+IFN-γ-stimulated pMBMECs is shown. Visualization of
VE-CadGFP in adherens junction (green) at different time points (left,
a and c); visualization of a CD8+ T cell by phase contrast superposed
with the VE-CadGFP staining (right, b and d). Red arrow points to where
diapedesis occurs with a loss of GFP staining at t = 12.5 min compared
to t = 3.5 min. Scale bar = 5 μm. (B) Transcellular diapedesis of a CD8+
T cell across TNF-α+IFN-γ-stimulated pMBMECs is shown. Visualiza-
tion of VE-CadGFP in the adherens junction (green) at different time
points (left, a and c); visualization of a CD8+ T cell by phase contrast
superposed with VE-CadGFP staining (right, b and d). Red arrow points
to the place where diapedesis occurs leaving the GFP staining intact.
Scale bar = 5 μm. (C) Quantitative analysis of para- and transcellular
diapedesis of activated CD8+ T cells shown as percentage from the total
number T cells analyzed. All diapedesis events were set to 100%. Eval-
uation was done from 38 videos of 30 min, in which a total number of
530 arrested cells were evaluated (N = 530). Seventy six percent of CD8+
T cells used the transcellular pathway, while 24% used the paracellular
pathway.
but did not change the staining intensity or staining pattern for
ICAM-2 and PECAM-1 (Fig. 5A). Quantification of cell surface
staining of these adhesion molecules confirmed the significant
upregulation of ICAM-1 and VCAM-1 on pMBMECs after 16–20 h
of stimulation with TNF-α or TNF-α+IFN-γ, when compared to
NS pMBMECs (Fig. 5B). Interestingly, both inflammatory stimuli
led to a more prominent upregulation of cell surface expression of
ICAM-1 compared to VCAM-1. We observed a fivefold increased
cell surface staining for ICAM-1 but only a 1.5-fold increased stain-
ing for VCAM-1 on TNF-α-stimulated versus NS pMBMEC mono-
layers. TNF-α+IFN-γ even further increased cell surface expres-
sion of ICAM-1 by 18-fold over levels detected on NS pMBMEC
monolayers while VCAM-1 cell surface staining was only enhanced
1.8-fold compared to NS pMBMEC monolayers (Fig. 5B). At
the same time cell surface detection of ICAM-2 and PECAM-1
remained unchanged in NS and stimulated pMBMEC monolayers
(Fig. 5B). Taken together these data demonstrate that TNF-α and
to a larger degree TNF-α+IFN-γ induced a significant upregula-
tion of ICAM-1 and less so of VCAM-1 on the surface of pMBMECs
compared to NS pMBMECs. The ligands for ICAM-1 and VCAM-1,
namely LFA-1 and α4β1- and α4β7-integrin were expressed on
both activated CD8+ and CD4+ T cells (Supporting Information
Fig. 2A; Supporting Information Table 1). Although the differ-
ent CD8+ or CD4+ T-cell preparations showed some variations
in cell surface staining for these integrins, the variability among
the different CD8+ and CD4+ T-cell lines was comparable and did
not allow to distinguish activated CD8+ from CD4+ T cells. More
importantly, irrespective of their integrin cell surface expression
all activated CD8+ T-cell preparations more efficiently arrested on
pMBMECs compared to the different activated CD4+ T-cell prepa-
rations (Supporting Information Fig. 2B).
Endothelial ICAM-1 and ICAM-2 mediate increased
shear-resistant arrest of CD8+ T cells on pMBMECs
We have previously shown that endothelial ICAM-1 and ICAM-2
contribute to mediating shear-resistant arrest of encephalitogenic
CD4+ T cells to the BBB in vitro [23]. We therefore first addressed
the role of endothelial ICAM-1 in mediating the increased shear-
resistant arrest of CD8+ versus CD4+ T cells on pMBMECs isolated
from ICAM-1null C57BL/6mice.We found that absence of endothe-
lial ICAM-1 led to a slight but not quite significant reduction of the
shear-resistant arrest of CD8+ T cells on TNF-α+IFN-γ-stimulated
pMBMECs when compared to wild-type (WT) pMBMECs from 45
± 19 to 37 ± 12 cells per FOV and on TNF-α-stimulated pMBMECs
from 33 ± 16 to 23 ± 6 cells per FOV (Supporting Information 4).
At the same time absence of endothelial ICAM-1 had only a minor
effect on the shear-resistant arrest of activated CD4+ T cells. When
compared to WT pMBMECs, the arrest of CD4+ T cells on ICAM-
1null pMBMECs was reduced from 30 ± 15 to 26 ± 12 T cells per
FOV on TNF-α+IFN-γ-stimulated pMBMECs and from 17 ± 3 to
15 ± 8 cells per FOV on TNF-α-stimulated pMBMECs (Supporting
Information Fig. 5).
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Figure 5. Cytokine stimulation of pMBMECs leads
to upregulation of ICAM-1 and VCAM-1. Analy-
sis of the surface expression of VCAM-1, ICAM-1,
ICAM-2, and PECAM-1 on confluent pMBMECs fol-
lowing stimulation with TNF-α and TNF-α+IFN-γ
for 16–20 h compared to NS pMBMECs (A) IF stain-
ings of VCAM-1, ICAM-1, ICAM-2, and PECAM-1
on NS, TNF-α and TNF-α+IFN-γ-stimulated pMB-
MEC monolayers are shown in false color white.
Blue, DAPI staining for nuclei. Scale bar, 20 μm.
(B) Quantitative analysis of cell surface protein
expression levels of VCAM-1, ICAM-1, ICAM-2,
and PECAM-1 on NS, TNF-α and TNF-α+IFN-γ-
stimulated pMBMECs as determined by on-cell
Western and infrared imaging is shown. Expres-
sion levels are displayed relative to the respective
NS sample, which was set to 1.0. Bars show the
mean ± SD (n = 4).*p < 0.05;**p < 0.01; ***p < 0.001;
****p < 0.0001; One-way ANOVA, followed by the
Tukey multiple comparison test.
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To determine if absence of the additional β2-integrin ligand
ICAM-2 on pMBMECs affected the increased arrest of activated
CD8+ versus CD4+ T cells on the inflamed BBB in vitro we studied
the interaction of CD8+ versus CD4+ T cells on pMBMECs isolated
from ICAM-1null/ICAM-2−/− C57BL/6 mice under physiological
flow in vitro. In the absence of endothelial ICAM-1 and ICAM-2
the increased arrest of CD8+ T cells versus CD4+ T cells observed
on NS and stimulated WT pMBMECs was completely abrogated
(Fig. 6A and B). Under NS conditions 2 ± 1 CD8+ T cells per
FOV versus 7 ± 2 CD4+ T cells per FOV were found to arrest on
ICAM-1null/ ICAM-2−/− pMBMECs under flow. After stimulation
of ICAM-1null/ ICAM-2−/− pMBMECs with TNF-α or TNF-α+IFN-γ
arrest of both, CD8+ and CD4+ T cells was increased with 15 ± 4
or 33 ± 3 (p < 0.0001 versus NS) CD8+ T cells per FOV and 18 ±
3 or 31 ± 2 (p < 0.0001 versus NS) CD4+ T cells per FOV arrested
on ICAM-1null/ ICAM-2−/− pMBMECs, respectively. Compared to
the total arrest on WT pMBMECs, the T-cell arrest of CD8+ but
not of CD4+ T cells on ICAM-1null/ ICAM-2−/− pMBMECs was
significantly decreased (p < 0.0001) both in the absence (NS)
and presence of TNF-α ± IFN-γ (Fig. 6 A and B and Support-
ing Information Videos 6–8). Thus, the increased arrest of CD8+
T cells compared to CD4+ T cells observed on WT pMBMECs
was mediated by the two endothelial LFA-1 ligands ICAM-1
and ICAM-2. Furthermore, on ICAM-1null/ ICAM-2−/− pMBMECs
arrested CD8+ and CD4+ T cells failed to polarize as visible by
their roundish shape, which could easily be distinguished from
the polarized shape arrested T cells obtain on WT pMBMECs
(Fig. 6B, Supporting Information Videos 1, 2, 3, 6, 7, 8).
We next asked if the remaining arrest of CD8+ and CD4+
T cells observed on ICAM-1null/ ICAM-2−/− pMBMECs was
mediated by α4-integrin-mediated interaction with endothelial
VCAM-1. Indeed, antibody mediated inhibition of VCAM-1 but
especially of α4-integrins completely abrogated shear-resistant
arrest of both, CD8+ and CD4+ T cells on TNF-α+IFN-γ-stimulated
ICAM-1null/ICAM-2−/− pMBMECs in a comparable manner
(Fig. 6C). T-cell arrest of both, CD8+ and CD4+ T cells was sig-
nificantly reduced in the presence of anti-VCAM-1 (p < 0.05) or
anti-α4-integrin antibody (p < 0.01) whereas the total arrest of
CD8+ compared to CD4+ T cells within the three conditions ana-
lyzed was comparable (Fig. 6C).
Taken together, these observations highlight that although
α4-integrin-mediated interaction with endothelial VCAM-1 con-
tributes to the arrest of both, activated CD8+ and CD4+ T cells,
the increased arrest of CD8+ versus CD4+ T cells on TNF-α and
TNF-α+IFN-γ-stimulated pMBMECs solely relies on the β2-
integrin ligands ICAM-1 and ICAM-2. Indeed, when comparing the
adhesion of activated CD8+ versus CD4+ T cells on recombinant
ICAM-1 versus VCAM-1 we observed that under static conditions
unlike activated CD4+ T cells, activated CD8+ T cells preferentially
adhere on ICAM-1 and less on VCAM-1 (Supporting Information
Fig. 5A). These findings suggested that activated CD8+ T cells
more efficiently interact with ICAM-1 compared to CD4+ T cells.
Therefore, we asked if activated CD8+ T cells display higher num-
bers of high-affinity LFA-1 molecules on their surface when com-
pared to activated CD4+ T cells. To this end, we investigated cell
surface binding of soluble ICAM-1 as an indicator of the presence
of high-affinity LFA-1 employing flow cytometry. Activated CD8+
T cells but not CD4+ T cells showed slight binding of soluble
ICAM-1 that could be further enhanced in the presence of Mn2+
(Supporting Information Fig. 5B and data not shown). Interest-
ingly, binding of soluble ICAM-1 to CD8+ T cells was equally
observed on both, N4 and Q4 stimulated OT1 cells underscoring
that the affinity of the peptide/TCR interaction does not influence
LFA-1 affinity on the surface of activated CD8+ T cells (Support-
ing Information Fig. 5 B). Similarly, the lack of binding of soluble
ICAM-1 on CD4+ T cells and its low induction of binding in the
presence of Mn2+ was also observed for other TCRtg as well as
polyclonal encephalitogenic CD4+ T-cell populations (data not
shown). These observations point to a difference in the ability of
activated CD8+ compared to CD4+ T cells to rapidly activate a
conformational change of their cell surface LFA-1 toward its high-
affinity conformation allowing for high avidity binding to ICAM-1
(Supporting Information Fig. 5 B).
Lack of endothelial ICAM-1 and ICAM-2 abrogates
CD4+ but not CD8+ T-cell diapedesis across pMBMECs
Considering the similar number of CD8+ and CD4+ T cells arrest-
ing on ICAM-1null/ICAM-2−/− pMBMECs, we next asked if the dif-
ferences observed in the postarrest dynamic interaction of CD8+
and CD4+ T cells on WT pMBMECs were also abrogated in the
absence of endothelial ICAM-1 and ICAM-2. To this end, we per-
formed a visual frame-by-frame offline analysis of the time-lapse
videos, in which we quantified the dynamic behavior of CD4+ and
CD8+ T cells arrested on NS, TNF-α, and TNF-α+IFN-γ-stimulated
ICAM-1null/ ICAM-2−/− pMBMECs by assigning each arrested
CD4+ and CD8+ T cell to six groups (i) Stalling T cells detach-
ing during the observation period, (ii) T cells remaining stalled,
and (iii) stalling T cells that crossed the pMBMEC monolayer in
the observation period, (iv) T cells that crawled and detached, (v)
T cells that crawled for the entire observation period, and finally
(vi) T cells that crossed the pMBMEC monolayer after crawling
(Supporting Information Video 3). Absence of endothelial ICAM-1
and ICAM-2 abrogated the ability of both, CD4+ and CD8+
T cells to crawl on NS and stimulated pMBMECs. Thus, the major-
ity of CD8+ and CD4+ T cells remained stalled on ICAM-1null/
ICAM-2−/− pMBMECs, however, with a significantly increased
proportion of T cells detaching during the observation time when
compared to WT pMBMECs (Figs. 7 and 2). Interestingly, stalled
CD8+ T cells and to a lesser extent stalled CD4+ T cells were still
able to cross the NS and stimulated pMBMEC monolayers in the
absence of endothelial ICAM-1 and ICAM-2 (Fig. 7). Hereby, a
significant difference in the diapedesis rates of stalling but not
of crawling T cells was observed on TNF-α+IFN-γ-stimulated
pMBMECs, with 23 ± 3% CD8+ versus 11 ± 2% CD4+ stalling
T cells still able to cross the endothelial monolayer (Fig. 7). Taken
together, these observations demonstrate that endothelial ICAM-1
and ICAM-2 are essential for crawling of both, activated CD4+ and
CD8+ T cells and contribute to sustained shear-resistant adhesion
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Figure 6. Endothelial ICAM-1 and ICAM-2 medi-
ate increased shear-resistant arrest of CD8+ T cells
compared to CD4+ T cells on pMBMECs. Anal-
ysis of the postarrest CD4+ and CD8+ T-cell
interactions with (NS, TNF-α-stimulated (TNF-α)
and TNF-α and IFN-γ (TNF-α+IFN-γ) stimulated
pMBMECs isolated from ICAM-1null/ICAM-2−/−
C57BL/6 mice under physiological flow was
observed by live cell imaging over 20 min.
(A) Mean numbers of arrested CD8+ T cells (red
bars) and CD4+ T cells (blue bars) per FOV on
ICAM-1null//ICAM-2−/− pMBMECs perfused in a
1:1 ratio are shown on NS, TNF-α-stimulated
(TNF-α) and TNF-α and IFN-γ costimulated (TNF-
α+IFN-γ) ICAM-1null//ICAM-2−/− pMBMECs. For
allowing a comparison to T-cell arrest under WT
conditions values from Figure 1 are shown in
the background in gray scale. Data are shown as
mean ± SEM (n = 10 for NS, n = 14 for TNF-α,
n = 29 for TNF-α+IFN-γ). One-way ANOVA, fol-
lowed by the Tukey multiple comparison test.
(B) Representative images from time-lapse videos
showing the arrested CellTrackerGreen (CMFDA)
or CellTrackerOrange (CMTMR) labeled CD8+ and
CD4+ T cells on NS, TNF-α-stimulated (TNF-α)
and TNF-α+IFN-γ costimulated (TNF-α+IFN-γ)
ICAM-1null//ICAM-2−/− pMBMECs at 30 to 40 s
after increase of the flow rate. The color of
the CD8 or CD4 label indicates the CellTracker
dye used for labeling CD8+ and CD4+ T cells
in the respective assay. (C) Mean numbers of
arrested CD8+ T cells and CD4+ T cells per FOV
on TNF-α+IFN-γ-stimulated ICAM-1null/ICAM-2−/−
pMBMECs perfused in a 1:1 ratio are shown.
ICAM-1null/ICAM-2−/− pMBMECs were incubated
with anti-VCAM-1 antibody (6C7.1) and CD8+ and
CD4+ T cells incubated with anti-α4-integrin anti-
body (PS/2) for 20 min prior to the experiment.
Data are shown as mean ± SEM (n = 5 for each
condition). The asterisks indicate statistically sig-
nificant results in comparison to TNF-α+IFN-γ-
stimulated ICAM-1null/ICAM-2−/− pMBMECs with-
out additional treatment of T cells or pMBMECs.
Two-way ANOVA, followed by the Sidak’s multi-
ple comparisons test.
of CD4+ and CD8+ T cell on pMBMECs. Interestingly, CD8+ T cells
rely less than CD4+ T cells on endothelial ICAM-1 and ICAM-2 to
undergo diapedesis across the BBB.
Discussion
The migration of activated T cells into the CNS is a hallmark
of MS and its animal model EAE. Inhibition of immune cell
trafficking into the CNS with the humanized anti-α4-integrin
antibody natalizumab is a successful therapeutic regimen for the
treatment of MS but comes with a risk for progressive multifocal
leukoencephalopathy, an often fatal disease caused by JC virus
infection of oligodendrocytes, suggesting that natalizumab may
also target CD8+ T-cell-mediated CNS immune surveillance [31].
Therapeutic efficacy of blocking α4-integrins was discovered in
EAE focusing our current insight into the molecular mechanisms
involved in immune cell trafficking to the CNS largely on
encephalitogenic CD4+ T cells. Nevertheless, the context of EAE
has been used to also address molecular mechanisms involved
in the migration of CD8+ T cells into the CNS largely confirming
that like for CD4+ T cells, α4β1-integrin but not α4β7-integrin
is involved in the trafficking of CD8+ T cells to the CNS during
EAE [7, 27, 32]. However, studying the molecular mechanisms
initiating CD8+ T-cell migration into the CNS in the context of EAE
bears limitations [24]. Previous in vivo live cell imaging studies in
our laboratory aiming to investigate the interaction of activated
OVA-specific TCRtg CD8+ T (OT1) cells with inflamed spinal
cord microvessels in mice suffering from CD4+ T-cell mediated
EAE pointed to components missing in the set of traffic signals
required to induce efficient OVA-specific CD8+ T-cell migration
across the inflamed BBB into the CNS [24]. In contrast, activated
OVA-specific CD4+ T cells readily cross the BBB during CD4+
T-cell driven EAE [33] underlining that the activation state rather
than the antigen-specificity controls at least CD4+ T-cell migration
across the BBB during EAE. It is therefore tempting to speculate
that efficient CD8+ T-cell migration across the BBB requires traf-
ficking cues that are absent in classical EAE. Indeed, in contrast to
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Figure 7. Lack of endothelial ICAM-1 and
ICAM-2 abrogates diapedesis of CD4+ but not
of CD8+ T cells across pMBMECs. (A) Postar-
rest behavior of CD8+ and CD4+ T cells on
NS, TNF-α-stimulated (TNF-α) andTNF-α+IFN-γ
costimulated (TNF-α+IFN-γ) ICAM-1null//ICAM-
2−/− pMBMECs. As T-cell crawling is abrogated
on ICAM-1null//ICAM-2−/− pMBMECs each T cell
was assigned to one of three categories, which
are shown in the staple bars as follows: Stalling
with diapedesis (black), stalling (dark gray) and
stalling with detachment (light gray). The num-
ber of arrested T cells per FOV (A) was set to
100% and the three categories are displayed in
percent. Bars show mean ± SEM (n = 10 for NS,
n = 14 for TNF-α, n = 29 for TNF-α+IFN-γ). Nor-
mality testing was performed with D’Agostino
and Pearson normality test (omnibus K2) before
differences between the stalling and crawl-
ing fraction were analyzed with the one-way
ANOVA, followed by the Tukey multiple com-
parison test. (Accompanying movies are pro-
vided as Supporting Information Videos 6–
8). (B) Percentage of overall CD4+ and CD8+
T-cell diapedesis irrespective of prior crawling
or stalling is shown. p values compare the dia-
pedesis rate of stalling CD4+ and CD8+ T cells.
One-way ANOVA, followed by the Tukey mul-
tiple comparison test. NS and TNF-α = not sig-
nificant; TNF-α+IFN-γ = ****p < 0.00001.
CD4+ T cells [33–35] recognition of their cognate antigen on the
BBB might contribute to CD8+ T cell migration across the BBB.
This is supported by the observation that intracerebral injection of
their cognate peptide antigen initiated CNS infiltration of circulat-
ing CD8+ T cells expressing an MHC class I restricted transgenic
TCR specific for this antigen [1, 36]. It thus seems that peptide-
loaded MHC class I molecules present on the luminal side of the
BBB endothelial cells triggered transmigration of CD8+ T cells in
an antigen-specificmanner. This process will, however, only be rel-
evant as part of a pathogenetic mechanism, in which such peptides
derived from sequestered or released self-antigens from the CNS
parenchyma or from infectious agents do in fact reach this site.
To recapitulate the CD8+ T-cell component in CNS autoim-
munity, a number of transgenic mouse models expressing model
antigens such as OVA or hemagglutinin specifically in cells of
the CNS have been established [37–40]. These models were
designed to study the migration of CD8+ T cells isolated from
well-characterized TCRtg mouse lines (OT1, CL4-TCR) expressing
MHC class I restricted TCRs by employing adoptive transfer exper-
iments of the respective activated CD8+ T cells analogous to those
inducing EAE by the transfer of encephalitogenic CD4+ T cells. In
general, induction of clinical disease has proven to be more diffi-
cult in these CD8+ T-cell driven autoimmune neuroinflammatory
models requiring either high number of preactivated CD8+ T cells
to trigger a clinical disease [4, 41] or the necessity of additional
peripheral infectious triggers [5, 6, 42]. Nevertheless, CD8+ T cells
do cross the BBB in these CD8+ T-cell induced neuroinflammatory
models. These models have allowed to define molecular mecha-
nisms such as a contribution of junctional adhesion molecule B
in the migration of CD8+ T cells across the BBB in vivo that are
distinct from those observed for CD4+ T cells in neuroinflamma-
tion [7, 43]. At the same time, as in CD4+ T-cell driven classical
EAE, thesemodels—due to their CD8+ T-cell driven nature—again
do not allow for a direct comparison of the molecular mechanisms
involved in CD8+ versus CD4+ T-cell migration across the BBB in
vivo.
In the current study, we therefore decided to rather compare
side by side the migration of activated TCR tg CD8+ and CD4+
T cells across the BBB in a well-established dynamic in vitro flow
assay [9, 23, 24, 26] that has proven to reliably recapitulate CD4+
T-cell interaction with the BBB as observed in vivo [9, 10, 33].
We here demonstrate significant differences in the multistep
extravasation of activated CD4+ and CD8+ T cells across pMB-
MECs as an in vitro model for the mouse BBB. Foremost, we
found that significantly higher number of CD8+ than CD4+ T cells
arrested on pMBMECs under noninflammatory and inflammatory
conditions. Arrest of both T-cell subsets was found to be inde-
pendent of Gαi-mediated GPCR-dependent integrin activation
confirming previous observations that integrin-mediated adhesion
of effector/memory T cells is distinct from that of na¨ıve T cells. On
the surface of na¨ıve T cells integrins are not constitutively active
and rather require “inside-out” signals initiated by chemokine
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receptors or the TCR allowing to change the integrin conforma-
tion on the cell surface leading to increased affinity for ligand
binding [18, 44]. Thus, na¨ıve T cells require the presence of
immobilized chemokines on the endothelial surface to arrest and
subsequently crawl to sites permissive for diapedesis [30, 45].
In contrast, effector/memory T cells were previously reported to
display spontaneously adhesive LFA-1 on their surface allowing
them to arrest on endothelial ligands under flow in the absence
of additional triggers [17, 19, 20, 30, 46]. Our present study
confirmed that activated CD4+ and CD8+ T cells do not require
Gαi-mediated inside-out activation of integrins to arrest and
crawl on the BBB under flow in vitro. Increased arrest of CD8+
T cells over CD4+ T cells on pMBMECs under flow was rather
mediated by endothelial ICAM-1 and ICAM-2 instead of VCAM-1
suggesting a prominent role of LFA-1 in mediating shear-resistant
arrest of CD8+ T cells on the BBB in vitro. Cell surface levels
of LFA-1 were found to be comparable on the different CD4+
and CD8+ T-cell preparations investigated. However, activated
CD8+ T cells showed increased adhesion to immobilized and
soluble recombinant ICAM-1 and rapid Mn2+-induced activation
of LFA-1 when compared to CD4+ T cells. These observations
imply that compared to activated CD4+ T cells, activated CD8+
T cells display a higher proportion of high-affinity LFA-1 on their
surface and more rapidly activate the conformational change of
LFA-1 toward the high-affinity stage allowing for fast maturation
of strong adhesive contacts of CD8+ T cells to the endothelial
LFA-1 ligands ICAM-1 and ICAM-2.
Interestingly, an influence of the TCR peptide/MHC affinity on
increased CD8+ T cell over CD4+ T-cell arrest on the BBB under
physiological flow in vitro could be excluded. Although we con-
firmed that the interaction of the OT1 TCR with the intermediate
affinity peptide Q4 (SIIQFEKL) is less potent in stimulating activa-
tion of OT1 cells when compared to the high-affinity peptide N4
(SIINFEKL) [29] this did not reduce the increased arrest of OT1
CD8+ cells compared to CD4+ T cells on pMBMECs under flow.
Our observations point to potential differences in signaling
pathways regulating integrin-mediated adhesion in activated
CD8+ versus CD4+ T cells. The signaling pathways discussed to
mediate integrin-mediated adhesion of T cells to the endothelium
under flow include Src-family kinases, phospholipase C, PI3-kinase
pathways as well as regulation of intracellular calcium and the
T-cell actin cytoskeleton [21, 22, 30, 46, 47]. Our present
observations suggest that compared to activated CD4+ T cells,
activated CD8+ T cells more efficiently use LFA-1 mediated
downstream signaling cascades leading to the rapid maturation
and adhesion strengthening of their contacts on the BBB under
flow and thus their increased arrest on the pMBMECs when
compared to CD4+ T cells.
Differences in LFA-1 activation on CD8+ versus CD4+ T cells
will exert different forces on endothelial ICAM-1 and ICAM-2,
which will translate to differences in downstream mechanosignal-
ing in the endothelial cells possibly leading to different dynamics
in the formation of ICAM-1 and possibly ICAM-2-enriched docking
structures on the BBB endothelium. Such docking structures have
been described to be enriched in ICAM-1, VCAM-1, and F-actin
and have been shown to be required for transcellular and para-
cellular diapedesis of T cells [ 23–26, 48]. A role for endothelial
ICAM-2 in these docking structures has not yet been reported.
However, downstream signals triggered by the cytoplasmic tail
of endothelial ICAM-1 have been shown to contribute to suc-
cessful T-cell diapedesis [23, 26, 37, 49]. Based on our obser-
vations it is tempting to speculate that CD8+ T cells by exerting
stronger focal forces on endothelial ICAM-1 combined with ICAM-
2 more efficiently trigger the local endothelial signaling cascades
involved in the formation of such docking structures favoring their
stalling behavior on the endothelium, which finally induces their
transcellular diapedesis across the BBB under flow close to the site
of their arrest. In contrast, slower maturation of integrin-mediated
adhesive contacts by CD4+ T cells on the BBB mainly via ICAM-1
[26] might require continuous crawling on endothelial ICAM-1,
which over time will lead to the integration of ICAM-1 down-
stream signals in the endothelium sufficient to trigger formation
of docking structures allowing for CD4+ T-cell diapedesis prefer-
entially via paracellular sites.
Our observations are in apparent contrast to a previous study,
which has shown CD8+ T-cell migration across the BBB to be inde-
pendent of LFA-1/ ICAM-1 interactions under static conditions
[7, 27]. It thus remains to be shown if the critical contribution of
LFA-1/ICAM-1 in the interaction of activated CD8+ T cells with the
BBB observed by us can only be observed under conditions of flow.
In summary, our side-by-side comparison of the multistep
migration of activated CD8+ T cells versus CD4+ T cells across the
BBB in vitro has allowed to define significant differences in the
strategies used by CD8+ T cells versus CD4+ T cells to cross the
BBB under physiological flow. We have identified a combined role
for endothelial ICAM-1 and ICAM-2 in triggering the increased
arrest of activated CD8+ T cells compared to CD4+ T cells to
the BBB, which followed by their stalling lead to their rapid and
mainly transcellular diapedesis. These findings support the idea
that molecular mechanisms that preferentially mediate the migra-
tion of CD8+ T cells versus CD4+ T cells across the BBB do exist
and that identification of such pathways will set the stage to more
accurately foresee CNS-specific adverse effects of the increasing
numbers of therapies targeting T-cell trafficking or even depleting
peripheral T cells in many chronic inflammatory diseases. Addi-
tionally, this will allow to identify novel therapeutic targets within
the successful framework of therapeutic targeting of immune cell
trafficking to the CNS for the treatment of MS allowing to specif-
ically block CNS recruitment of destructive T cells, while leaving
the migration of protective T cell subsets into the CNS unaffected.
Materials and methods
Mice
C57BL/6J mice were obtained from Harlan (Horst, Netherlands)
and Janvier (Genest Saint Isle, France). ICAM-1null (Icam1tm1Alb)
mice, generated by deletion of the entire coding region of the
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ICAM-1 gene [50],were kindly provided by D.C. Bullard (Birm-
ingham, Alabama, USA). ICAM-2−/− (Icam2tm1Jcgr) mice were
described previously [24, 51]. ICAM-1null//ICAM-2−/− mice were
created by crossbreeding as described [23, 25]. VE-CadGFP knock-
in mice were provided by D. Vestweber (Mu¨nster, Germany)
[25, 26, 52]. OT1 mice (C57BL/6-Tg(TcraTcrb)1100Mjb) contain
a transgenic TCR that recognizes OVA residues 257–264 (SIIN-
FEKL) in the context of H2Kb [25, 26, 53] and were kindly pro-
vided by Federica Sallusto (IRB, Bellinzona). OT2 mice (C57BL/6-
Tg(TcraTcrb)425Cbn) contain a transgenic TCR that recognizes
OVA residues 323–339 in the context of H2-Ab1 (I-Ab) [23, 54]
and were kindly provided by Klaus Okkenhaug (Babraham Insti-
tute, Cambridge, UK). All gene targeted mice were backcrossed
to the C57BL/6J background for at least ten generations. All mice
were bred in individually ventilated cages under specific pathogen-
free conditions. Animal procedures were performed according to
the Swiss legislation on the protection of animals and approved
by the Veterinary Office of the Kanton Bern.
Antibodies and dyes
For flow cytometry (*and blocking of integrins) the following
antibodies or hybridoma culture supernatants were used: CD4
PerCP (rat IgG2b, clone RM4-5, Biolegend 100538, San Diego,
USA), CD8a PE (rat IgG2a, clone 53–6.7, Biolegend 100708),
CD25 APC (where APC is allophycocyanin; rat IgG2b, clone
3C7, Biolegend 101910), CD29 PE/ β1 (armenian hamster IgG,
clone HMb1-1, Biolegend 102207), CD45 FITC/ CD45 PE/ CD45
APC/CD45 PerCP (rat IgG2b, clone 30F11, Biolegend 103108).
The hybridomas anti-CD45 (clone M1/9), anti-LFA-1 (rat IgG2a,
clone FD441.8), *anti-α4-integrin (rat IgG2b, clone PS/2), anti-
β7-integrin (rat IgG2a, clone Fib 504), anti-α4β7-integrin (rat
IgG2a, clone DATK 32) and anti-CD4 (rat IgG2b, clone GK1.5)
were purchased from American Type Culture Collection (ATCC,
Rockville, USA). The supernatant for anti-PSGL-1 (rat IgG1, clone
4RA10) was a kind gift from D. Vestweber. All supernatants were
used as previously described [23, 25, 55–58].
The following isotype controls were used: PE-conjugated
rat IgG2b, κ (clone A95-1, BD Pharmingen 556925, San Diego,
USA), PerCP-conjugated rat IgG2a, κ (clone RTK2758, Biolegend
400530), APC-conjugated rat IgG2a, κ (clone RTK2758, Biole-
gend 400612), APC-conjugated rat IgG2b,κ (clone RTK4530,
Biolegend 400612) and the hybridoma culture supernatant rat
anti-human CD44 (clone 9B5, ATCC). The following second stage
antibodies were used: PE-conjugated goat F(ab)2 anti-rat IgG
(Life Technologies GmbH A10544, Darmstadt, Germany), PE-
conjugated mouse anti-armenian and syrian hamster IgG Cocktail
(clone G94-90.5, BD Pharmingen 12355B), FITC-conjugated
mouse anti-rat IgG2b (clone RG7/11, BD Pharmingen 553900)
and APC-conjugated goat anti-rat IgG (Life Technologies GmbH
A10540).
For IF stainings, on-cell Western of pMBMECs and soluble
ICAM-1 stainings the following hybridoma culture supernatants
and for *function-blocking the respective endotoxin-free purified
antibodies were used: rat-anti-mouse ICAM-1 (clone 25ZC7), rat-
anti mouse ICAM-2 (clone 3C4), rat-anti-mouse VCAM-1 (clone
9DB3; *clone 6C7.1), rat-anti-mouse PECAM-1 (clone Mec13.3),
rat-anti mouse Mac-1 (*clone M1/70) and rat-anti-mouse LFA-1
(*clone FD441.8) and rat anti-human CD44 (clone 9B5, ATCC),
used as isotype control. All antibodies were described previously
[31, 56]. Rat-anti-mouse LFA-1 *cloneM17/4was purchased from
BD Pharmingen (cat. 553337). As second stage, the antibody goat
anti-rat Cy3 (H+L) (Jackson ImmunoReseach, Suffolk, UK) and
PE-conjugated Donkey F(ab’)2 Anti-Human IgG (H+L) (Jackson
ImmunoResearch, 709-116-149, West Grove, USA) were used.
PTX was obtained from List Biological Laboratories (Campbell,
CA). PTX-B oligomer (PTX-B) lacking the enzymatic activity of
PTX was used as a control and was purchased from Calbiochem
(San Diego, CA).
pMBMECs isolation
pMBMECs were isolated from C57BL/6J mice (6-10-wk old)
exactly as described [7, 23, 25–27, 31, 59]. Cytokine stimula-
tion of pMBMECs was performed by adding recombinant mouse
TNF-α (10 ng/mL, Vitaris AG, Baar, Switzerland) in the absence
or presence of additional recombinant mouse IFN-γ (100 U/mL,
PreproTech EC Ltd., London, UK), for 16–20 h.
CD8+ and CD4+ T-cell isolation and culture
To obtain highly pure and importantly also homogeneously acti-
vated T-cell subsets we chose to isolate CD8+ and CD4+ T cells
from the well-characterized TCR transgenice mouse lines OT1 and
OT2, respectively. Isolation of CD4+ and CD8+ T cells from these
mice allowed to achieve comparable antigen-specific T-cell acti-
vation for both T-cell subsets. Activated T cells were established
according to a previously described method [24]. In brief, spleen
and peripheral lymph nodes were collected from OT1 (for CD8+
T cells) and OT2 (for CD4+ T cells) C57BL/6J mice and single cell
suspensions were obtained after DNAse I (0,2 mg/mL; Bo¨hringer,
Mannheim, Germany) and liberase (0.4 mg/mL; Roche Applied
Sciences, Switzerland) digestion and filtration through a sterile
100 μm nylon mesh. A total of 7.5 × 106 cells were plated per 60
mm diameter petri dish (PD 60) in RPMI supplemented with 10%
FBS, 2 mM L-glutamine, 1 mM sodium pyruvate, 100 U penicillin–
streptomycin, 0,05 mM 2-mercaptoethanol. For TCR-specific stim-
ulation, OT1 and OT2 T cells were stimulated with their spe-
cific OVA peptides (OVA peptide aa257-264/SIINFEKL/N4 (10
μg/mL) for OT1 and OVA peptide aa323-339 (5 μg/mL) for
OT2) (Peptides International, Louisville, KY, USA) [24, 54, 60].
When specifically mentioned, OT1 T cells were also stimulated
with intermediate affinity altered peptide ligand Q4 (OVA pep-
tide aa257-264variant/SIIQFEKL, 10 μg/mL) [28, 29]. On day
3, IL-2 (5 ng/mL) was added overnight in each dish. The next
day, freshly activated live OT1 and OT2 T-cell blasts were isolated
by Nycoprep 1.077 A (Axis-Shield, Dundee, UK) density gradient
centrifugation. These T-cell blasts were cultured for another 2 to 4
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days before use in experiments or for freezing of aliquots in liquid
nitrogen. Comparable OT1- and OT2 T-cell activation was ensured
by assessing antigen-specific T-cell proliferation by 3H-thymidine
incorporation during the last 16 h of a 4 day culture exactly as
described [33, 56, 61]. Purity of the CD4+ OT2 T effector cell
population was increased by additional purification via negative
magnetic bead selection (EasySepTM Mouse CD4+ T Cell Isola-
tion Kit, STEMCELL Technologies SARL, Cologne, Germany). The
purity of CD8+/CD4+ T cells was 97 ± 4%/96 ± 2%, respectively,
as determined by flow cytometry.
In vitro live-cell imaging
Live-cell imaging of T-cell interaction with pMBMECs under flow
was performed as described with combined superfusion of OT1
and OT2 cells over pMBMECs [23–26, 33, 34]. The techni-
cal and methodological details of these studies including an in
depth description of the flow chamber setup have been described
before [24]. To distinguish OT1 and OT2 T cells, they were
labeled with Cell Tracker Orange (CMTMR) or Cell Tracker Green
(CMFDA, Molecular Probes, Eugene, OR) according to the man-
ufacturers’ instructions. To prevent staining artefacts, OT1 and
OT2 cells were alternately labeled with CMTMR or CMFDA in
different sets of experiments. OT1 and OT2 T cells were resus-
pended in Migration Assay Medium (DMEM with 5%FBS, 25 mM
HEPES, 2% glutamine) in a concentration of 0.85 × 106 cells/mL
and allowed to accumulate on the flow chamber at a low shear
(0.1 dyn/cm2) for 5 min. The exact cell ratio of OT1 to OT2 cells
within each cell suspension was controlled by flow cytometry.
Quantitative evaluation of the videos was corrected for the mixing
factor if necessary. Dynamic interaction of activated OT1 and OT2
T cells with the pMBMECs was recorded under physiological shear
flow (1.5 dyn/cm2) for 15 to 25 min (objective EC Plan Neoflur
20X/0.4) with phase or differential interference contrast and fluo-
rescence illumination using a monochrome charge-coupled device
camera (AxioCam MRm Rev, Carl Zeiss). Image analysis was per-
formed using ImageJ software (ImageJ software, National Insti-
tute of Health, Bethesda, MD, USA) using the manual tracking,
chemotaxis and migration tools, and color-merging plug-ins. The
number of arrested T cells was counted at 30 s after onset of
enhanced shear flow (1.5 dyn/cm2). Using the 63x objective (Plan-
Neofluar" 63x/1.3) with a FOV of 136 × 102 μm and in addition
by overlaying the differential interference contrast channel with
the GFP fluorescence channel, para- and transcellular diapedesis
of T cells across monolayers of VE-Cad-GFP pMBMECs were ana-
lyzed. Diapedesis with transient loss of the junctional GFP signal
was classified as paracellular, whereas diapedesis events, which
did not affect the junctional VE-Cad-GFP signal, were categorized
as transcellular diapedesis.
On-cell Western
Quantitative measurement of cell surface molecules expression
was assessed by on-Cell Western as already described [25, 26].
pMBMECs were grown to confluency on 96 (SPL, Life science) or
384-well plates (Greiner Bio-One, Monroe, NC) and were stim-
ulated or not by cytokines for additional 16–20 h. Primary anti-
bodies were incubated for 15 min at room temperature. After
three washes with washing buffer C (WBC, DMEM supplemented
with 5% FCS and 25nM HEPES 1×), cells were incubated for
another 15 min at RT with the appropriate Alexa 680-conjugated
secondary antibody. Cells were washed three times with WBC
and fixed with 1% PFA. The fluorescence intensity was measured
by the Odyssey Infrared Imaging System (LI-COR Biosciences,
Bad Homburg, Germany). Background intensity, defined by the
isotype control staining, was subtracted from all the values to
ensure the specificity of the staining. Values were then normal-
ized to the NS condition.
IF staining
IF stainings of pMBMECs were performed as previously described
[23, 25]. In brief, pMBMECs were cultured until confluency and
were left NS or stimulated with TNF-α or TNF-α +IFN-γ for 16–20
h. Cells were washed with WBC (HBSS + HEPES + BSA) and fixed
for 10 min with PBS 1%PFA. Cells were then pretreated with PBS
0.1% TWEEN for 10mins at RT. First antibodies were added for
45 min at RT and after several washes with WBC, the appropriate
secondary antibody (goat anti-rat Cy3, 1/300, Jackson Immunore-
search) was added for 45 min at RT. After further washes the cells
were mounted with Mowiol supplemented with DAPI to label the
nuclei and analyzed under the fluorescence microscope.
Binding assays on recombinant CAMs
For assessment of T-cell binding to recombinant cell adhesion
molecules, 18 field teflon slides (Thermo Fisher Scientific Inc.,
Waltham, USA) were precoated with protein A (BioVision, Axxora
Europe, Lausen, Switzerland) for 1 h at 37°C. After washing steps
with binding assay medium (BAM: DMEM with 25 mM HEPES
and 5% FCS) and blocking with 1.5% BSA, purified recombinant
mouse ICAM-1 Fc, (R&D Systems, Abingdon, UK), recombinant
VCAM-1 Fc (R&D Systems) and as control DNER Fc (R&DSystems)
were overlaid in a concentration of 10 μg/mL and incubated for 2
h at 37°C. After washing with BAM and blocking with 1.5% BSA,
T cells were added in BAM (5 × 106 cells/mL) and incubated on a
rotating platform for 30 min at 4°C. After washing in slides were
fixed in 2.5% glutaraldehyde for 2 h at room temperature. Cells
bound per FOV were counted using an ocular with a 10 ×10 field
counting grid.
Flow cytometry
To characterize OT1 and OT2 effector/memory T cells, six param-
eter flow cytometry analysis was performed exactly as described
before at the day the T cells were used in the functional assays
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and additionally at different time points after isolation, freezing, or
thawing [62]. Antibody incubation was performed for 30 min with
primary Abs and the PE or APC-conjugated secondary antibody at
4°C. Before acquisition using a FACSCalibur and CellQuest soft-
ware (BD Biosciences), cells were fixed in 1% formaldehyde/PBS
(pH 7.4). Data analysis was performedwith FlowJo software (Tree
Star, Ashland, OR).
Soluble ICAM-1 binding assay
To analyze β2-integrin affinity on OT1 and OT2 T cells, we per-
formed a soluble ICAM-1-binding assay as previously described
[63]. As a positive control T cells were preincubated with 2
mM MnCl2 and as a negative control with a cocktail of function
blocking anti-β2-integrin antibodies (anti-LFA-1 (M17/4; 20
μg/mL) and anti-Mac1 (M1/70; 50 μg/mL) for 10 min at
RT. Recombinant mouse ICAM-1 Fc, (R&D Systems, Abingdon,
UK, final concentration 20 μg/mL) was preincubated with PE-
conjugated donkey F(ab’)2 anti-human IgG (H + L) (Jackson
ImmunoResearch) for 10 min at 20°C prior to incubation for 3
or 5 min at 37°C with the CD4+ and CD8+ T cells. Following fixa-
tion in 7.4% formaldehyde soluble ICAM-1 binding to the T cells
was assessed by flow cytometry.
Statistical analysis
Statistical analysis was performed using GraphPad Prism software
(GraphPad, San Diego, CA). If not otherwise stated, normality
testing was performed with D’Agostino and Pearson normality
test (omnibus K2) before differences between two groups were
analyzed with the one-way or two-way ANOVA. Follow up analysis
was performed with Tukey multiple comparison test. Data are
shown as mean ± SEM.
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